{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:51:20Z","timestamp":1781891480392,"version":"3.54.5"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.retram.2026.103577","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:07:17Z","timestamp":1772870837000},"page":"103577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive review on artificial intelligence driven approaches for vaccine development: Current advances, challenges, and future prospects"],"prefix":"10.1016","volume":"74","author":[{"given":"Jyoti","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2026.103577_bib0001","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.retram.2026.103577_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0003","first-page":"7277","article-title":"Revolutionizing cancer treatment: unleashing the power of viral vaccines, monoclonal antibodies, and proteolysis-targeting chimeras in the new era of immunotherapy","volume":"9","author":"Mohite","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.retram.2026.103577_bib0004","first-page":"4773","article-title":"Enhancing global health security through technology-driven vaccine development: a case for artificial intelligence in designing next-generation vaccines","volume":"41","author":"Monrad","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.retram.2026.103577_bib0005","first-page":"170","article-title":"Machine learning approaches for COVID-19 detection with routine blood tests","volume":"511","author":"Ogunleye","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.retram.2026.103577_bib0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0007","series-title":"Immunization agenda 2030: a global strategy to leave no one behind","year":"2020"},{"key":"10.1016\/j.retram.2026.103577_bib0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.retram.2026.103577_bib0009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/frai.2020.00065","article-title":"Artificial intelligence for COVID-19 drug discovery and vaccine development","volume":"3","author":"Keshavarzi Arshadi","year":"2020","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.retram.2026.103577_bib0010","first-page":"3037","article-title":"Secure computational model for handling COVID-19 pandemic","volume":"67","author":"Zahid","year":"2021","journal-title":"Comput Mater Contin"},{"key":"10.1016\/j.retram.2026.103577_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.retram.2026.103577_bib0012","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.dsx.2020.04.012","article-title":"Artificial intelligence (AI) applications for COVID-19 pandemic","volume":"14","author":"Vaishya","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.retram.2026.103577_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1613\/jair.1.12162","article-title":"Mapping the landscape of artificial intelligence applications against COVID-19","volume":"69","author":"Bullock","year":"2020","journal-title":"J Artif Intell Res"},{"key":"10.1016\/j.retram.2026.103577_bib0014","first-page":"477","article-title":"Pfizer\u2019s real-world vaccine data praised by experts","volume":"593","author":"Bender","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.retram.2026.103577_bib0015","first-page":"5815","article-title":"Forecasting vaccine demand: an artificial intelligence-based modeling framework","volume":"39","author":"Zeng","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.retram.2026.103577_bib0016","series-title":"Artificial intelligence in the battle against coronavirus (COVID-19): a survey and future research directions","author":"Nguyen","year":"2020"},{"key":"10.1016\/j.retram.2026.103577_bib0017","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(20)30845-X","article-title":"Beware of the second wave of COVID-19","volume":"395","author":"Xu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0018","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.retram.2026.103577_bib0019","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00151-8","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 vaccines: where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.retram.2026.103577_bib0021","volume":"103","author":"Olawade","year":"2024","journal-title":"Malaria vaccination in Africa: a mini-review of challenges and opportunities"},{"key":"10.1016\/j.retram.2026.103577_bib0022","first-page":"2454","article-title":"Artificial intelligence and machine learning approaches for vaccine development: opportunities and challenges","volume":"26","author":"Patel","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.retram.2026.103577_bib0023","first-page":"110","article-title":"Machine learning-based epitope prediction for vaccine development","volume":"163","author":"Zhu","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.retram.2026.103577_bib0024","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.retram.2026.103577_bib0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.retram.2026.103577_bib0027","doi-asserted-by":"crossref","DOI":"10.1186\/1745-7580-6-S2-S1","article-title":"Computer aided selection of candidate vaccine antigens","volume":"6","author":"Flower","year":"2010","journal-title":"Immunome Res"},{"key":"10.1016\/j.retram.2026.103577_bib0028","first-page":"1","article-title":"Emerging vaccine informatics","volume":"2010","author":"He","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.retram.2026.103577_bib0029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2010.03330.x","article-title":"Immunoinformatics: an integrated scenario","volume":"131","author":"Tomar","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.retram.2026.103577_bib0030","first-page":"1","article-title":"B cell epitope prediction","volume":"1","author":"Ponomarenko","year":"2009","journal-title":"Struct Bioinform Immune Recept"},{"key":"10.1016\/j.retram.2026.103577_bib0031","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2026.103577_bib0032","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311","volume":"36","author":"Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2026.103577_bib0033","first-page":"e139","article-title":"Automated generation and evaluation of specific MHC binding predictive tools: NetMHCpan, methods and applications","volume":"3","author":"Bui","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.retram.2026.103577_bib0034","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0035","first-page":"1399","article-title":"Vaccines: past, present and future","volume":"9","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2026.103577_bib0036","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0037","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2026.103577_bib0038","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.retram.2026.103577_bib0039","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.retram.2026.103577_bib0041","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0042","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0043","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol"},{"key":"10.1016\/j.retram.2026.103577_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.retram.2026.103577_bib0045","first-page":"1","article-title":"Synthetic mRNA: production, introduction into cells, and physiological translation","volume":"969","author":"Brito","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.retram.2026.103577_bib0046","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.retram.2026.103577_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1111-6","article-title":"Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response","volume":"15","author":"Edwards","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2026.103577_bib0048","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.2015.973859","article-title":"mRNA transcript therapy","volume":"14","author":"Weissman","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.retram.2026.103577_bib0049","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2011.03.007","article-title":"Tumor vaccination using messenger RNA: prospects of a future therapy","volume":"23","author":"Kreiter","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.retram.2026.103577_bib0051","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther Deliv"},{"key":"10.1016\/j.retram.2026.103577_bib0052","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent adv ances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0053","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.retram.2026.103577_bib0054","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2026.103577_bib0056","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2026.103577_bib0057","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0058","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2026.103577_bib0059","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime\u2013boost COVID-19 vaccine","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0060","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(21)02000-6","article-title":"Efficacy, safety, and lot-to-lot immunogenicity of BBV152 vaccine","volume":"398","author":"Ella","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103577_bib0061","first-page":"201","article-title":"Role of artificial intelligence in fast-track drug discovery and vaccine development for COVID-19","volume":"8","author":"Bali","year":"2022","journal-title":"Nov AI Data Sci Adv Sustain COVID-19 Era"},{"key":"10.1016\/j.retram.2026.103577_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-024-00238-3","article-title":"The role of artificial intelligence in pandemic responses","volume":"6","author":"Gawande","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.retram.2026.103577_bib0063","first-page":"1","article-title":"Tools for prediction and validation of epitopic regions on protein targets, Front","author":"Tufail","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.retram.2026.103577_bib0064","first-page":"199","article-title":"Regulatory insights into artificial intelligence in drug delivery","author":"Sharma","year":"2024","journal-title":"AI Innov Drug Deliv Pharm Sci"},{"key":"10.1016\/j.retram.2026.103577_bib0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.22214\/ijraset.2023.49519","article-title":"AI-based virtual assistant using Python","volume":"11","author":"Manojkumar","year":"2023","journal-title":"Int J Res Appl Sci Eng Technol"},{"key":"10.1016\/j.retram.2026.103577_bib0066","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/9781119865728.ch11","article-title":"Artificial intelligence and machine learning applications in vaccine development","author":"Sarmadi","year":"2023","journal-title":"Bioinform Tools Pharm Drug Prod Dev"},{"key":"10.1016\/j.retram.2026.103577_bib0067","first-page":"201","article-title":"Role of artificial intelligence in fast-track drug discovery and vaccine development for COVID-19","author":"Bali","year":"2022","journal-title":"Nov AI Data Sci Adv Sustain COVID-19 Era"},{"key":"10.1016\/j.retram.2026.103577_bib0068","doi-asserted-by":"crossref","DOI":"10.1177\/11779322211002168","article-title":"The relevance of bioinformatics applications in vaccine discovery","volume":"15","author":"Chukwudozie","year":"2021","journal-title":"Bioinform Biol Insights"},{"key":"10.1016\/j.retram.2026.103577_bib0069","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/vaccines11020221","article-title":"Immunoinformatics approaches for vaccine design","volume":"11","author":"Rawat","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.retram.2026.103577_bib0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8874","article-title":"Machine learning multimodal model for delirium risk stratification","volume":"8","author":"Friedman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.retram.2026.103577_bib0071","first-page":"85","article-title":"Keras and TensorFlow: a hands-on experience","author":"Joseph","year":"2021","journal-title":"Adv Deep Learn Eng Sci"},{"key":"10.1016\/j.retram.2026.103577_bib0072","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4842-3516-4_2","article-title":"Understanding and working with Keras","author":"Manaswi","year":"2018","journal-title":"Deep Learn Appl Using Python"},{"key":"10.1016\/j.retram.2026.103577_bib0073","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12033-024-01124-7","article-title":"The evolving landscape of cervical cancer","volume":"67","author":"Aswathy","year":"2025","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.retram.2026.103577_bib0074","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40364-025-00764-4","article-title":"Artificial intelligence as an antibody design tool","volume":"13","author":"Dewaker","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.retram.2026.103577_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.artmed.2018.12.010","article-title":"Antigenic: an improved prediction model","volume":"94","author":"Rahman","year":"2019","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.retram.2026.103577_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan for MHC class I prediction","volume":"61","author":"Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"10.1016\/j.retram.2026.103577_bib0077","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2026.103577_bib0078","series-title":"Belgrade Bioinform. Conf","article-title":"Using AI to design antibodies","volume":"62","author":"Rako\u010devi\u0107","year":"2023"},{"key":"10.1016\/j.retram.2026.103577_bib0079","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood-2023-187238","article-title":"Artificial intelligence for autoantigen discovery","volume":"142","author":"Medina","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.retram.2026.103577_bib0080","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7205241","article-title":"Artificial intelligence-based data-driven strategy to accelerate research, development, and clinical trials of COVID vaccine","volume":"2022","author":"Sharma","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2026.103577_bib0081","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41541-023-00795-8","article-title":"Development and use of machine learning algorithms in vaccine target selection","volume":"9","author":"Bravi","year":"2024","journal-title":"npj Vacc"},{"key":"10.1016\/j.retram.2026.103577_bib0082","unstructured":"Baker TC. Improving detection of MHC-presented immunopeptides, PhD Thesis, Univ. British Columbia 2024."},{"key":"10.1016\/j.retram.2026.103577_bib0083","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.csbj.2022.08.035","article-title":"Computational design of a multiepitope vaccine against Klebsiella pneumoniae","volume":"20","author":"Cuscino","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.retram.2026.103577_bib0084","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.micpath.2008.11.006","article-title":"MrkD adhesin-mediated immunity in Klebsiella pneumoniae","volume":"46","author":"Li","year":"2009","journal-title":"Microb Pathog"},{"key":"10.1016\/j.retram.2026.103577_bib0085","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2023.09.002","article-title":"Machine learning improves neoantigen prediction","volume":"56","author":"M\u00fcller","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.retram.2026.103577_bib0086","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-020-00822-6","article-title":"Integrated in silico immunogenetic platform for COVID-19","volume":"13","author":"Ward","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.retram.2026.103577_bib0087","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/cells11071182","article-title":"Biotechnological perspectives to combat COVID-19","volume":"11","author":"Aileni","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.retram.2026.103577_bib0088","article-title":"AI construction of hypoallergenic mite vaccine","volume":"15","author":"Qin","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0089","article-title":"Computational design of multi-epitope HEV vaccine","volume":"18","author":"Anwar","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2026.103577_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1347550","article-title":"Artificial intelligence in veterinary clinical practice","volume":"11","author":"Akinsulie","year":"2024","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.retram.2026.103577_bib0091","article-title":"AI-driven adjuvant development for cancer vaccines","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1357217","article-title":"Personalized cancer vaccine design using AI","volume":"15","author":"Kumar","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103577_bib0093","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/17460441.2020.1791076","article-title":"Artificial intelligence and systems biology for vaccine design","volume":"15","author":"Russo","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.retram.2026.103577_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105057","article-title":"Progress from empirical to rational vaccine design","volume":"140","author":"Soleymani","year":"2022","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.retram.2026.103577_bib0095","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/21645515.2019.1670035","article-title":"Computational tools for modern vaccine development","volume":"16","author":"Sunita","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.retram.2026.103577_bib0096","first-page":"467","article-title":"In silico tools for peptide-based vaccines","volume":"18","author":"Dhanda","year":"2017","journal-title":"Br Bioinform"},{"key":"10.1016\/j.retram.2026.103577_bib0097","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/bs.mim.2024.08.002","article-title":"The power of AI in viral vaccine production","volume":"56","author":"Sarkar","year":"2025","journal-title":"Methods Microbiol"},{"key":"10.1016\/j.retram.2026.103577_bib0098","first-page":"3","article-title":"Artificial intelligence for vaccine design","volume":"3","author":"McCaffrey","year":"2021","journal-title":"Vaccine Des Methods Protoc"},{"key":"10.1016\/j.retram.2026.103577_bib0099","article-title":"Untethered microrobots for active drug delivery","volume":"11","author":"Liu","year":"2022","journal-title":"Adv Heal Mater"},{"key":"10.1016\/j.retram.2026.103577_bib0100","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4155\/bio-2021-0096","article-title":"Analytical methods for evaluating pandemic vaccines","volume":"13","author":"Baldwin","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.retram.2026.103577_bib0101","series-title":"Applications of machine learning in biopharmaceutical process development and manufacturing","author":"Khuat","year":"2023"},{"key":"10.1016\/j.retram.2026.103577_bib0102","doi-asserted-by":"crossref","first-page":"e3291","DOI":"10.1002\/btpr.3291","article-title":"Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals","volume":"38","author":"Puranik","year":"2022","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.retram.2026.103577_bib0103","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tibtech.2022.08.007","article-title":"Artificial intelligence and machine learning applications in biopharmaceutical manufacturing","volume":"41","author":"Rathore","year":"2023","journal-title":"Trends Biotechnol"},{"issue":"022","key":"10.1016\/j.retram.2026.103577_bib0104","article-title":"Artificial intelligence-based data-driven strategy to accelerate research, development, and clinical trials of COVID vaccine","volume":"2","author":"Sharma","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2026.103577_bib0105","first-page":"17","article-title":"AI in healthcare: using cutting-edge technologies to revolutionize vaccine development and distribution","volume":"1","author":"Abbasi","year":"2023","journal-title":"J Inov Hum"},{"key":"10.1016\/j.retram.2026.103577_bib0106","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/info14120665","article-title":"Revolutionizing vaccine development for COVID-19: a review of AI-based approaches","volume":"14","author":"Ghosh","year":"2023","journal-title":"Information"},{"key":"10.1016\/j.retram.2026.103577_bib0107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aiopen.2020.07.001","article-title":"AI-driven drug discovery: a boon against COVID-19?","volume":"1","author":"Kaushik","year":"2020","journal-title":"AI Open"},{"key":"10.1016\/j.retram.2026.103577_bib0108","article-title":"Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design","volume":"22","author":"Lv","year":"2021","journal-title":"Br Bioinform"},{"key":"10.1016\/j.retram.2026.103577_bib0109","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.retram.2026.103577_bib0110","series-title":"Artificial intelligence in vaccine development: significance and challenges ahead, Handbook of Artificial Intelligence in Drug Delivery","first-page":"467","author":"Kannan","year":"2023"},{"key":"10.1016\/j.retram.2026.103577_bib0111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4018\/JDM.2020040105","article-title":"Artificial intelligence (AI) ethics: ethics of AI and ethical AI","volume":"31","author":"Siau","year":"2020","journal-title":"J Database Manag"},{"key":"10.1016\/j.retram.2026.103577_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2021.100314","article-title":"A high-level overview of AI ethics","volume":"2","author":"Kazim","year":"2021","journal-title":"Patterns"},{"key":"10.1016\/j.retram.2026.103577_bib0113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42256-019-0088-2","article-title":"The global landscape of AI ethics guidelines","volume":"1","author":"Jobin","year":"2019","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.retram.2026.103577_bib0114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12913-023-09237-6","article-title":"Ethical considerations of the vaccine development process and vaccination: a scoping review","volume":"23","author":"Jalilian","year":"2023","journal-title":"BMC Health v Res"},{"key":"10.1016\/j.retram.2026.103577_bib0115","first-page":"339","article-title":"Harnessing AI for vaccine breakthroughs: revolutionizing development, distribution, and ethics","volume":"5","author":"Thatoi","year":"2024","journal-title":"J Artif Intell Gen Sci"},{"key":"10.1016\/j.retram.2026.103577_bib0116","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2016.07.016","article-title":"Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection","volume":"34","author":"Rasmussen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.retram.2026.103577_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108437","article-title":"Computational strategies in Klebsiella pneumoniae vaccine design: navigating the landscape of in silico insights","volume":"76","author":"Douradinha","year":"2024","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.retram.2026.103577_bib0118","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/vaccines10081367","article-title":"Current vaccine platforms in enhancing T-cell response","volume":"10","author":"Ura","year":"2022","journal-title":"Vaccines"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:56:05Z","timestamp":1781888165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2452318626000140"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103577","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on artificial intelligence driven approaches for vaccine development: Current advances, challenges, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103577"}}